PAVmed (PAVM) Invested Capital (2018 - 2025)

PAVmed's Invested Capital history runs 7 years deep, the most recent figure standing at $11.1 million for Q4 2025.

• On a quarterly basis, Invested Capital fell 61.86% year-over-year to $11.1 million in Q4 2025; TTM through Dec 2025 was $31.4 million, a 75.64% decrease from a year earlier, with the FY2025 full-year figure at $11.1 million, down 61.86% from the prior year.
• Invested Capital climbed to $11.1 million in Q4 2025 per PAVM's latest filing, from $6.9 million in the prior quarter.
• Across five years, Invested Capital topped out at $45.5 million in Q1 2024 and bottomed at $6.6 million in Q1 2025.
• The 4-year median for Invested Capital is $33.6 million (2022), against an average of $29.0 million.
• Across the five-year window, Invested Capital soared 45.73% in 2023 and tumbled 85.51% in 2025, its largest moves.
• Year by year, Invested Capital stood at $33.6 million in 2022, then surged by 31.35% to $44.2 million in 2023, then plunged by 34.16% to $29.1 million in 2024, then plunged by 61.86% to $11.1 million in 2025.
• Per Business Quant, the three latest PAVM Invested Capital figures stand at $11.1 million (Q4 2025), $6.9 million (Q3 2025), and $6.8 million (Q2 2025).